These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 1650129)

  • 1. Interferon therapy for acute posttransfusion non-A, non-B hepatitis: response with respect to anti-hepatitis C virus antibody status.
    Ohnishi K; Nomura F; Nakano M
    Am J Gastroenterol; 1991 Aug; 86(8):1041-9. PubMed ID: 1650129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of posttransfusion non-A, non-B acute and chronic hepatitis with human fibroblast beta-interferon: a preliminary report.
    Ohnishi K; Nomura F; Iida S
    Am J Gastroenterol; 1989 Jun; 84(6):596-600. PubMed ID: 2499184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon therapy in HCV-positive mixed cryoglobulinaemia: viral and host factors contributing to efficacy of the therapy.
    Mazzaro C; Carniello GS; Colle R; Doretto P; Mazzi G; Crovatto M; Santini GF; Tulissi P; Gregoretti M; Mazzoran L; Russo A; Silvestri F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):343-50. PubMed ID: 9476189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up after successful interferon therapy of acute hepatitis C.
    Wiegand J; Jäckel E; Cornberg M; Hinrichsen H; Dietrich M; Kroeger J; Fritsch WP; Kubitschke A; Aslan N; Tillmann HL; Manns MP; Wedemeyer H
    Hepatology; 2004 Jul; 40(1):98-107. PubMed ID: 15239091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-hepatitis C antibodies in patients with chronic non-A, non-B hepatitis: relation to disease progression and effect of interferon alpha.
    Yoshioka K; Kakumu S; Hayashi H; Shinagawa T; Wakita T; Ishikawa T; Itoh Y; Takayanagi M
    Am J Gastroenterol; 1991 Oct; 86(10):1495-9. PubMed ID: 1928044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of antibody to Y19 protein in nonA and nonB chronic liver disease].
    Sakashita H
    Fukuoka Igaku Zasshi; 1993 Apr; 84(4):159-72. PubMed ID: 7686128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of antibody to hepatitis C virus in prospectively followed transfusion recipients with acute and chronic non-A, non-B hepatitis.
    Alter HJ; Purcell RH; Shih JW; Melpolder JC; Houghton M; Choo QL; Kuo G
    N Engl J Med; 1989 Nov; 321(22):1494-500. PubMed ID: 2509915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and chronology of occurrence of anti-HCV in non-A non-B post-transfusional hepatitis.
    Barcena R; Martín-de-Argila C; Ulibarrena C; Erdozain JC; Gil Grande LA; Mateos M
    Rev Esp Enferm Dig; 1993 Oct; 84(4):245-8, 241-4. PubMed ID: 8292436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute sporadic non-A, non-B, non-C, non-D, non-D, non-E hepatitis.
    Rochling FA; Jones WF; Chau K; DuCharme L; Mimms LT; Moore B; Scheffel J; Cuthbert JA; Thiele DL
    Hepatology; 1997 Feb; 25(2):478-83. PubMed ID: 9021967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant interferon-alpha and ursodeoxycholic acid versus interferon-alpha alone in the treatment of chronic hepatitis C: a randomized clinical trial with long-term follow-up.
    Angelico M; Gandin C; Pescarmona E; Rapicetta M; Del Vecchio C; Bini A; Spada E; Baroni CD; Capocaccia L
    Am J Gastroenterol; 1995 Feb; 90(2):263-9. PubMed ID: 7847298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Hepatitis C antibodies in acute Non-A, Non-B hepatitis].
    Zellweger U; Havelka J; Zala G; Altorfer J; Joller-Jemelka HI; Schmid M; Bühler H
    Schweiz Med Wochenschr; 1991 May; 121(20):761-3. PubMed ID: 1711714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extrahepatic immunological manifestations of hepatitis C virus in dialysis patients.
    Canavese C; Hollò Z; Ciccone G; Ghisetti V; Barbui A; Fop F; Martina G; Forgnone F; Novo P; Thea A; Grill A; Marchiaro G
    J Nephrol; 2000; 13(5):352-9. PubMed ID: 11063139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of chronic non-A,non-B hepatitis with recombinant human alpha interferon. A preliminary report.
    Hoofnagle JH; Mullen KD; Jones DB; Rustgi V; Di Bisceglie A; Peters M; Waggoner JG; Park Y; Jones EA
    N Engl J Med; 1986 Dec; 315(25):1575-8. PubMed ID: 3097544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus in chronic liver disease and hepatocellular carcinoma in Taiwan.
    Chen DS
    Princess Takamatsu Symp; 1995; 25():27-32. PubMed ID: 8875606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of antibodies to E2-protein of GB virus-C/hepatitis G virus in patients with acute posttransfusion hepatitis.
    Hwang SJ; Lu RH; Chan CY; Chang FY; Lee SD
    J Med Virol; 1999 Jan; 57(1):85-9. PubMed ID: 9890427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of antibodies to hepatitis C virus in transfused children with cancer.
    Monteleone PM; Andrzejewski C; Kelleher JF
    Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):309-13. PubMed ID: 7978047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-hepatitis C virus immunoglobulin M antibody in patients with chronic hepatitis type C.
    Kikuchi T; Onji M; Michitaka K; Ohta Y
    Hepatogastroenterology; 1992 Dec; 39(6):525-8. PubMed ID: 1336473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term treatment of cryptogenic hepatitis C using recombinant interferon alpha].
    Hopf U; Möller B; König V; Küther S; Lobeck H; Huhn D
    Z Gastroenterol; 1990 Sep; 28(9):453-7. PubMed ID: 2125776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.